NCT04423250

Brief Summary

assess the impact of the intervention of a clinical pharmacist expert in sterile medical devices

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 23, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
Last Updated

February 13, 2025

Status Verified

February 1, 2025

Enrollment Period

7 months

First QC Date

June 5, 2020

Last Update Submit

February 11, 2025

Conditions

Surgery

Outcome Measures

Primary Outcomes (1)

  • identify compliance with the appropriate use of sterile medical devices

    1 day

Interventions

impact of the intervention of a clinical pharmacist with expertise in sterile medical devices on non-compliances related to the use of sterile medical devicesOTHER

\- Failure to trace, Lack of product information, absence of product in the operating room

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized for scheduled surgery in the UDG (Urology Digestive Gynecology) operating room.

You may qualify if:

  • \- The patient must be a member or beneficiary of a health insurance plan.
  • The patient is managed for scheduled surgery (full hospitalization or outpatient) in the UDG (Urology Digestive Gynecology) operating room.

You may not qualify if:

  • The subject is under judicial protection.
  • The subject (or his/her legal representative) has expressed his/her opposition to participate in the study.
  • The patient is undergoing emergency surgery in the UDG (Urology Digestive Gynecology) operating room.
  • It is not possible to give informed information about the subject.
  • Translated with www.DeepL.com/Translator (free version)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NIMES

Nîmes, 30029, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

March 23, 2018

Primary Completion

October 31, 2018

Study Completion

October 31, 2018

Last Updated

February 13, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)